Oculus Innovative Sciences, Inc., has announced the sale of its remaining 1.65 million shares of Ruthigen. The stock was sold to an investor group at $2.75 per share for non-dilutive funding of $4.5 million. View the full release here.
News: Oculus sold Ruthigen stake for $4.5 Million $OCLS Read More »
Alcon, the global leader in eye care and a division of Novartis, has received an approval for CE mark for its AcrySof® IQ PanOptix® trifocal intraocular lens (IOL). The lens is used for patients undergoing cataract surgery. View the full release here.
News: Alcon IOL Lens Approved by CE $NVS Read More »
Genesis HealthCare Inc.,is acquiring 24 Skilled Nursing Facilities from Revera Inc. The realestate of 20 facilities will be also acquired on Longterm lease basis. View the full release here.
News: Genesis HealthCare to get 24 SNFs $GEN Read More »
CVS Health Inc.,has reduced its shares buy back Offer from $6 Billion to $5 Billion. The Step is taken to sustain the Debt/EBITDA level under 3.2 after the acquisitions of Omnicare and Target’s pharmacy businesses close. View the full release here.
News: CVS Health Reduced Buyback Offer $CVS Read More »
Oculus Innovative Sciences, Inc., has announced its annual results for FY-2011-15. The results shows 1.5% rise in Revenues now $13.9 Million and Net Loss down by 119.7% to -$1.5 Million. View the full earnings release here.
Earnings: Oculus Reduce Losses $OCLS Read More »
